文献速递衰弱、肌少症与跌倒老年慢病共病管理

大蒜素逆转衰老雄性Fischer 344大鼠的衰弱与骨质疏松

Allicin Reversed the Process of Frailty in Aging Male Fischer 344 Rats With Osteoporosis.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2020-01-01

本研究在13至21月龄雄性Fischer 344大鼠中评估长期灌胃大蒜素(4、8、16 mg·kg-1·d-1)对衰弱与骨质疏松的影响。大蒜素可降低衰弱指数评分、改善骨密度与骨生物力学特性,机制可能涉及增加低骨转换。

要点

  • 大蒜素可减轻衰老雄性大鼠的健康缺陷累积,降低衰弱指数评分。
  • 大蒜素可改善老年骨质疏松,提高骨密度并逆转不良骨生物力学特征。
  • 机制可能涉及同时提升骨形成与骨吸收,增加低骨转换。

核心结论

  • 长期口服大蒜素可减轻衰老过程中伴随骨质疏松的衰弱,为衰弱干预提供临床前证据。

研究设计与样本

  • 研究在13至21月龄雄性Fischer 344大鼠中进行,对照大鼠为6至9月龄,采用27项衰弱指数评估衰弱。
  • 大蒜素经长期灌胃给药,低剂量为4 mg·kg-1·d-1,中剂量为8 mg·kg-1·d-1,高剂量为16 mg·kg-1·d-1。
  • 骨质疏松通过双能X射线吸收法检测骨密度、三点弯曲试验测量生物力学性能及ELISA进行骨代谢分析来评估。

主要发现

  • 大蒜素可降低衰老雄性Fischer 344大鼠的衰弱指数评分,减少健康缺陷累积。
  • 大蒜素可保护对抗老年骨质疏松,机制可能涉及通过提升骨形成和骨吸收来增加低骨转换。
  • 大蒜素可提高骨密度,并有助于逆转与衰老相关的不良骨生物力学特征。

关键数值与推荐

  • 衰弱评估采用27项衰弱指数,基于量化成年雄性大鼠的健康相关缺陷。
  • 大蒜素低、中、高剂量分别为4 mg·kg-1·d-1、8 mg·kg-1·d-1、16 mg·kg-1·d-1。

临床怎么用

  • 该研究为临床前证据,提示大蒜素可能作为衰弱合并骨质疏松的潜在干预方向,但尚不能直接转化为临床推荐。

局限性

  • 研究为动物实验,结果外推至老年人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The research and development of pharmaceutical intervention is insufficient for the frail older adults, especially in preclinical stage for the frail individuals with osteoporosis. Garlic exerts an antiosteoporotic effect and its vital component allicin could protect organisms against aging. The present study aimed to investigate the effect of long-term intragastric administration of allicin (low dose of 4 mg·kg-1·d-1; middle dose of 8 mg·kg-1·d-1; high dose of 16 mg·kg-1·d-1) on frailty with osteoporosis in aging male Fischer 344 rats. Frailty was assessed with a 27-item frailty index based on quantifying health-related deficits in adult male rats varied from 13 to 21 months and in control rats from 6 to 9 months. Osteoporosis was appraised by bone mineral density detected by dual-energy X-ray absorptiometry, biomechanical properties measured by a three-point bending test, and bone metabolic analysis using ELISA. Allicin could attenuate frailty index scores by reducing the accumulation of health deficits in aging male Fischer 344 rats. Meanwhile, allicin could protect against senile osteoporosis, and the underlying mechanism may involve in increasing low bone turnover through elevation of both bone formation and bone resorption, and subsequently lead to increase of bone mineral density, contributing to reversing deleterious bone biomechanical features associated with aging. The present study reveals firstly that long-term oral administration with allicin attenuated frailty with osteoporosis during the process of aging, which provides a preclinical evidence for intervention of frailty.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Liu Y, You M, Shen J, et al. Allicin Reversed the Process of Frailty in Aging Male Fischer 344 Rats With Osteoporosis. J Gerontol A Biol Sci Med Sci. 2020. PMID: 31541608. doi:10.1093/gerona/glz205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。